Rockefeller Capital Management
AMRX icon

Rockefeller Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Rockefeller Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Sell
32,970
-76,989
-70% -$1.03M ﹤0.01% 2091
2025
Q4 		$1.39M Buy
+109,959
New +$1.26M ﹤0.01% 1404
2023
Q1 		– Sell
-1,218
Closed -$2K – 2052
2022
Q4 		$2K Sell
1,218
-25
-2% -$56 ﹤0.01% 3537
2022
Q3 		$2K Sell
1,243
-1
-0.1% -$3 ﹤0.01% 3550
2022
Q2 		$3K Buy
+1,244
New +$4.51K ﹤0.01% 3614

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Rockefeller Capital Management's AMRX Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 70% in Q1 2026, selling an estimated $1.03M and leaving 32,970 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Rockefeller Capital Management first reported a position in AMRX in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.39M in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Rockefeller Capital Management held 32,970 shares of Amneal Pharmaceuticals worth $410K as of Q1 2026.
  • Rockefeller Capital Management sold 76,989 Amneal Pharmaceuticals shares in Q1 2026, an estimated $1.03M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2091 holding.
  • Rockefeller Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2022 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Amneal Pharmaceuticals position peaked at $1.39M in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.